1 | medicines and medical devices | | | | | | | 5 | 0.29% |
2 | agency for medicines and | | | | | | | 3 | 0.18% |
3 | du médicament et des | | | | | | | 3 | 0.18% |
4 | for medicines and medical | | | | | | | 3 | 0.18% |
5 | linksnameministère de la santé | | | | | | | 3 | 0.18% |
6 | member linksnamefood and drug | | | | | | | 3 | 0.18% |
7 | safer use of medicines | | | | | | | 3 | 0.18% |
8 | way in medicinal product | | | | | | | 2 | 0.12% |
9 | make sure appropriate standards | | | | | | | 2 | 0.12% |
10 | in medicinal product safety | | | | | | | 2 | 0.12% |
11 | of the who pidm | | | | | | | 2 | 0.12% |
12 | sure appropriate standards and | | | | | | | 2 | 0.12% |
13 | medicinal product safety umc | | | | | | | 2 | 0.12% |
14 | countries around the world | | | | | | | 2 | 0.12% |
15 | most countries around the | | | | | | | 2 | 0.12% |
16 | food and drug administration | | | | | | | 2 | 0.12% |
17 | from most countries around | | | | | | | 2 | 0.12% |
18 | appropriate standards and systems | | | | | | | 2 | 0.12% |
19 | la pharmacie et des | | | | | | | 2 | 0.12% |
20 | product safety umc expands | | | | | | | 2 | 0.12% |
21 | data from most countries | | | | | | | 2 | 0.12% |
22 | and analyse data from | | | | | | | 2 | 0.12% |
23 | collect and analyse data | | | | | | | 2 | 0.12% |
24 | we collect and analyse | | | | | | | 2 | 0.12% |
25 | for medicines and health | | | | | | | 2 | 0.12% |
26 | safety umc expands the | | | | | | | 2 | 0.12% |
27 | médicament et des laboratoireslink | | | | | | | 2 | 0.12% |
28 | de la pharmacie et | | | | | | | 2 | 0.12% |
29 | more uppsala monitoring centre | | | | | | | 2 | 0.12% |
30 | read more uppsala monitoring | | | | | | | 2 | 0.12% |
31 | pharmacovigilance to enable safer | | | | | | | 2 | 0.12% |
32 | to enable safer use | | | | | | | 2 | 0.12% |
33 | enable safer use of | | | | | | | 2 | 0.12% |
34 | of health and human | | | | | | | 2 | 0.12% |
35 | standards and systems are | | | | | | | 2 | 0.12% |
36 | analyse data from most | | | | | | | 2 | 0.12% |
37 | use of medicines and | | | | | | | 2 | 0.12% |
38 | member linksnamecentre national de | | | | | | | 2 | 0.12% |
39 | adverse drug reaction monitoring | | | | | | | 2 | 0.12% |
40 | medicines and health products | | | | | | | 2 | 0.12% |